IGFBP2 and Familial prostate cancer: Two potential androgen binding sites have been identified via bioinformatic analysis of the region upstream from the IGFBP-2 transcription initiation site that may explain the effects of androgen treatment on IGFBP-2 gene expression as demonstrated in prostate cancer cells (57, 58).